Correlation Between Vanda Pharmaceuticals and Ikena Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vanda Pharmaceuticals and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vanda Pharmaceuticals and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vanda Pharmaceuticals and Ikena Oncology, you can compare the effects of market volatilities on Vanda Pharmaceuticals and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vanda Pharmaceuticals with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vanda Pharmaceuticals and Ikena Oncology.

Diversification Opportunities for Vanda Pharmaceuticals and Ikena Oncology

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Vanda and Ikena is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Vanda Pharmaceuticals and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Vanda Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vanda Pharmaceuticals are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Vanda Pharmaceuticals i.e., Vanda Pharmaceuticals and Ikena Oncology go up and down completely randomly.

Pair Corralation between Vanda Pharmaceuticals and Ikena Oncology

Given the investment horizon of 90 days Vanda Pharmaceuticals is expected to generate 1.66 times more return on investment than Ikena Oncology. However, Vanda Pharmaceuticals is 1.66 times more volatile than Ikena Oncology. It trades about 0.2 of its potential returns per unit of risk. Ikena Oncology is currently generating about 0.03 per unit of risk. If you would invest  466.00  in Vanda Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of  49.00  from holding Vanda Pharmaceuticals or generate 10.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Vanda Pharmaceuticals  vs.  Ikena Oncology

 Performance 
       Timeline  
Vanda Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Vanda Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong fundamental indicators, Vanda Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Ikena Oncology 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Ikena Oncology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Ikena Oncology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Vanda Pharmaceuticals and Ikena Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vanda Pharmaceuticals and Ikena Oncology

The main advantage of trading using opposite Vanda Pharmaceuticals and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vanda Pharmaceuticals position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.
The idea behind Vanda Pharmaceuticals and Ikena Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities